Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Left Ventricular Dysfunction With Enalapril and Carvedilol in Patients Submitted to Intensive Chemotherapy for the Treatment of Malignant Hemopathies

NCT01110824 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.

NCT NCT01110824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01110824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Left Ventricular Dysfunction With Enalapril and Carvedilol in Patients Submitted to Intensive Chemotherapy for the Treatment of Malignant Hemopathies
Lead sponsor
Hospital Clinic of Barcelona
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2008
Completion date
March 31, 2012
Enrollment
90 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, autologous hematopoietic stem cell transplantation, lymphoid neoplasm, lymphoma, multiple myeloma, precursor-cell lymphoblastic leukemia-lymphoma